These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 23752246

  • 1. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.
    Mol Psychiatry; 2014 Apr; 19(4):403-5. PubMed ID: 23752246
    [No Abstract] [Full Text] [Related]

  • 2. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C, Guirgis H, Votolato N.
    Am J Psychiatry; 2011 Oct; 168(10):1120. PubMed ID: 21969051
    [No Abstract] [Full Text] [Related]

  • 3. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
    Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, Huang H, Lek M, Neale BM, Ripke S, Shianna K, Szatkiewicz JP, Tropsha A, van den Oord EJ, Cascorbi I, Dettling M, Gazit E, Goff DC, Holden AL, Kelly DL, Malhotra AK, Nielsen J, Pirmohamed M, Rujescu D, Werge T, Levy DL, Josiassen RC, Kennedy JL, Lieberman JA, Daly MJ, Sullivan PF.
    Nat Commun; 2014 Sep 04; 5():4757. PubMed ID: 25187353
    [Abstract] [Full Text] [Related]

  • 4. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
    Legge SE, Walters JT.
    Pharmacogenomics; 2019 Mar 04; 20(4):279-290. PubMed ID: 30767710
    [Abstract] [Full Text] [Related]

  • 5. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr 04; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
    Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.
    Pharmacogenomics J; 2019 Apr 04; 19(2):211-218. PubMed ID: 29298994
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.
    Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, Koskimies S.
    J Clin Psychopharmacol; 2001 Feb 04; 21(1):4-7. PubMed ID: 11199946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
    Rubio JM, Kane JM, Tanskanen A, Tiihonen J, Taipale H.
    Lancet Psychiatry; 2024 Jun 04; 11(6):443-450. PubMed ID: 38697177
    [Abstract] [Full Text] [Related]

  • 11. Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.
    Dettling M, Cascorbi I, Roots I, Mueller-Oerlinghausen B.
    Arch Gen Psychiatry; 2001 Jan 04; 58(1):93-4. PubMed ID: 11146763
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M, Lewis CM.
    Pharmacogenomics; 2015 Jan 04; 16(9):915-7. PubMed ID: 26122865
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clozapine-induced agranulocytosis and its genetic determinants.
    Opgen-Rhein C, Dettling M.
    Pharmacogenomics; 2008 Aug 04; 9(8):1101-11. PubMed ID: 18681784
    [Abstract] [Full Text] [Related]

  • 17. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
    Güzelcan Y, Scholte WF.
    Tijdschr Psychiatr; 2006 Aug 04; 48(4):295-302. PubMed ID: 16955993
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
    Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H.
    Lancet Psychiatry; 2022 May 04; 9(5):353-362. PubMed ID: 35334224
    [Abstract] [Full Text] [Related]

  • 20. G-CSF Dosing to Prevent Recurrent Clozapine-Induced Agranulocytosis.
    Freeman GM, Martin BA, Hu RJ.
    Am J Psychiatry; 2016 Jun 01; 173(6):643. PubMed ID: 27245191
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.